Online inquiry

IVTScrip™ mRNA-Anti-IL13, CDP7766(Cap 1, 2-Thio-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ5596MR)

This product GTTS-WQ5596MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 2-Thio-UTP. It ecodes the monoclonal antibody that targets IL13 gene. The antibody can be applied in Asthma research.

Specifications
Product type	mRNA
Modified bases	2-Thio-UTP
5' Cap	Cap 1
Species	Humanized
RefSeq	NM_001354991.2
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	3596
UniProt ID	P35225

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-IL13, CDP7766(Cap 1, 2-Thio-UTP, 120 nt-poly(A)) (GTTS-WQ5596MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ13010MR	IVTScrip™ mRNA-Anti-CSF3R, PEG-G-CSF(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	PEG-G-CSF
GTTS-WQ4299MR	IVTScrip™ mRNA-Anti-SNCA, BIIB-054(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	BIIB-054
GTTS-WQ6622MR	IVTScrip™ mRNA-Anti-CD79B, DCDS0780A(Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	DCDS0780A
GTTS-WQ11373MR	IVTScrip™ mRNA-Anti-IGF, MEDI-573(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	MEDI-573
GTTS-WQ7905MR	IVTScrip™ mRNA-Anti-MAG, GSK-249320(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	GSK-249320
GTTS-WQ8435MR	IVTScrip™ mRNA-Anti-TLR3 Agonist, HspE7(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	HspE7
GTTS-WQ7138MR	IVTScrip™ mRNA-Anti-LHCGR, FE 999302(Cap 1, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	FE 999302
GTTS-WQ4183MR	IVTScrip™ mRNA-Anti-LAG3, BI-754111(Cap 0, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	BI-754111

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST